Abstract: Methods for decreasing rod gene expression in a retina, methods for decreasing the protein products expressed by rod genes in a retina, methods for treating a disease or condition treatable by decreasing rod gene expression or their protein products in a retina, and methods for treating a retinal disease in a subject.
Type:
Application
Filed:
June 20, 2019
Publication date:
December 19, 2019
Applicants:
University of Washington, The J. David Gladstone Institutes, a Testamentary Trust Established Under the Will of J. David Glads
Inventors:
Thomas A. Reh, Paul Nakamura, Sheng Ding
Abstract: Methods for decreasing rod gene expression in a retina, methods for decreasing the protein products expressed by rod genes in a retina, methods for treating a disease or condition treatable by decreasing rod gene expression or their protein products in a retina, and methods for treating a retinal disease in a subject.
Type:
Application
Filed:
March 28, 2016
Publication date:
May 10, 2018
Applicants:
University of Washington, The J. David Gladstone Institutes, a Testamentary Trust Established Under the Will of J. David Glads
Inventors:
Thomas A. Reh, Paul Nakamura, Sheng Ding
Abstract: The present invention relates to compounds including but not limited to of any one of formulas Ia, Ib, IIa, IIb, IIIa, IIIb, and IV to VI, VIIa, VIIb, VIIIa, VIIIb and VIIIc as described herein and their tautomers and/or pharmaceutically acceptable salts, compositions, and methods of uses thereof.
Type:
Application
Filed:
January 8, 2015
Publication date:
November 10, 2016
Applicant:
THE J. DAVID GLADSTONE INSTITUTES, A TESTAMENTARY TRUST ESTABLISHED UNDER THE WILL OF J. DAVID GLAD
Inventors:
Andrey S. Tsvetkov, Steven M. Finkbeiner, Michael A. Pleiss, Robert Greenhouse
Abstract: Compositions and methods are described herein for inducing reprogramming of non-pluripotent cells across lineage and differentiation boundaries to generate endodermal progenitor cells and hepatocytes. Compositions and methods for expansion of endodermal progenitor cells without loss of phenotype are also described herein.
Type:
Application
Filed:
December 20, 2014
Publication date:
June 25, 2015
Applicants:
The J. David Gladstone Institutes, a testamentary trust established under the Will of J. David Glads, The Regents of the University of California